Quinn Kneifl
Medical · Pender, NENPI 1023063401
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 113 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 27.9% of the total. 2025 is the largest year on record at $470, 2.7 times the $175 reported in 2021.
Across 113 payments — averaging $14.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$464
- Novartis$213
- Pfizer$146
- Astellas Pharma US Inc$127
- Amgen$120
- Novo Nordisk$98
- plus $493 from 17 others
What the payments were for
- Food & beverage$1,661100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 31 | $464 |
| Novartis | 15 | $213 |
| Pfizer | 10 | $146 |
| Astellas Pharma US Inc | 8 | $127 |
| Amgen | 9 | $120 |
| Novo Nordisk | 7 | $98 |
| Otsuka America Pharmaceutical, Inc. | 5 | $72 |
| Bayer | 4 | $62 |
| GSK | 4 | $53 |
| Lilly USA, LLC | 3 | $51 |
| AstraZeneca | 3 | $42 |
| Amarin Pharma, Inc. | 2 | $29 |
| Inspire Medical Systems, Inc. | 1 | $27 |
| E.r. Squibb & Sons, L.L.C. | 2 | $25 |
| KCI USA, Inc. | 1 | $20 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $15 |
| Intuitive Surgical | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
| Mimedx Group, Inc. | 1 | $14 |
| Merck | 1 | $14 |
| Boston Scientific | 1 | $13 |
| Idorsia Pharmaceuticals US Inc | 1 | $12 |
How this compares
$1,661 in reported general payments places this provider in the 75th percentile of 216 medical providers in Nebraska.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 72 | $47,700 |
| OzempicSemaglutide | 33 | $31,733 |
| MounjaroTirzepatide | 28 | $27,003 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 17 | $14,773 |
| RybelsusSemaglutide | 13 | $11,830 |
| TrulicityDulaglutide | 12 | $11,257 |
| XareltoRivaroxaban | 25 | $10,326 |
| Tresiba Flextouch U-100Insulin Degludec | 18 | $9,886 |
| Tresiba Flextouch U-200Insulin Degludec | 13 | $7,317 |
| BrilintaTicagrelor | 12 | $5,484 |
| SymbicortBudesonide/Formoterol Fumarate | 20 | $4,732 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $4,583 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 14 | $3,529 |
| Ezetimibe | 44 | $1,675 |
| Theophylline ErTheophylline Anhydrous | 12 | $1,657 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $146 | $47,70072 claims |
| Novo NordiskOzempic, Rybelsus | $98 | $43,56346 claims |
| Lilly USA, LLCMounjaro, Trulicity | $51 | $38,26040 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $53 | $19,35629 claims |
| AstraZenecaBrilinta, Symbicort | $42 | $10,21632 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 216 medical providers in Nebraska.
Other medical in Pender
- Connie FelberPender$1K
- Michelle SitzmanLincoln$206K
- Kaitlin MatthesLincoln$98K
- Kelly HooverOmaha$16K
- Lyndsey DegenhardtElkhorn$12K
- Jacob RidderOmaha$12K
- Angelika StevensOmaha$8K
- Jennelea MontanezOmaha$8K
- Shannon BusterPapillion$8K
- Jay ArthurLincoln$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.